In a few past years, GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) metamorphosed as a breakthrough therapy in type 2 diabetes and obesity. These medications have not only resulted in appreciable weight loss but also have quite unintendedly changed the scenery in aesthetic medicine. Many individuals losing large amounts of weight using GLP-1 therapy now turn to cosmetic procedures for addressing changes related to lost facial volume, loose skin, and body contouring. 

There has been, therefore, an important new nexus between medical weight loss and cosmetic dermatology. As more aesthetic practitioners picked up on the emerging need of this unique patient population, they modified their therapeutic approaches and treatment plans. 

Understanding GLP-1 Medications and Weight Loss

GLP-1 receptor agonists imitate natural hormones that lead to appetite suppression, hindrance of gastric emptying, and stimulation of insulin secretion. Initially considered for diabetes treatment, their strong effect on weight loss made these drugs a hit for the purposes of treating obesity (Rubino et al., 2021). Studies show that most patients can experience more than 15% of their body weight lost within a year of using them regularly (Wilding et al., 2021).  

While the gains may be impressive physiologically and metabolically, the result is often unplanned body sculpting effects. The most obvious of such changes appear on the face in the form of volume loss- terms popularly called “Ozempic face.”  

The Rise of ‘Ozempic Face’ and Aesthetic Concerns

A very typical change is that of the middle and lower face wherein fat pads that confer youthful contour to cheeks and temples begin reducing, thereby leading to hollowness or sagging skin and giving an appearance that is prematurely aged (Avram et al., 2023). Aesthetic clinics are flooded with individuals seeking restoration of lost volume and lift through dermal fillers, skin-tightening treatments, and even fat grafting.

The condition commonly referred to in the media as “Ozempic face” has generated high demand for a variety of rejuvenation treatments specifically for post-weight-loss patients. 

How GLP-1 Weight Loss Is Shaping Aesthetic Treatment Plans

Aesthetic professionals are increasingly modifying their approach for GLP-1 users. Some of the most common concerns and solutions include: 

1. Facial Volume Loss

  • Treatment: Fillers with hyaluronic acid (e.g. Juvederm, Restylane), Sculptra (poly-L-lactic acid), or fat grafting.
  • Goal: To re-establish midface volume, soften hollows, and restore youthful facial contours.

2. Skin Laxity

  • Treatment: Devices that non-invasively tighten the skin like radiofrequency microneedling (Morpheus8), ultrasound (Ultherapy), or laser resurfacing.
  • Goal: Increase the collagen and elastin production to correct the sagging or loose skin. 

3. Body Contouring

  • Treatment: The body-sculpting techniques are varied, so she can choose a combination of cryolipolysis (CoolSculpting), body skin tightening, and surgical options like skin excision.
  • Goal: The primary focus here should be to deal with loose skin and local fat pockets after considerable weight loss.

Psychological and Emotional Impacts

GLP-1 drugs enhance health and self-esteem, while some physical changes can lead to distress or dissatisfaction. Patients may feel ambivalent about their weight loss journey in case of unpredictable aging in the face or sagging skin. Aesthetic treatments may provide a way to make peace with these changes and elevate self-esteem, but only when these treatments are offered with a gentle and ethical approach (de Sousa et al., 2022). 

The Role of Aesthetic Providers

The aesthetic practitioner is one who actively engages GLP-1 users in all aspects of the post-weight loss transformation, namely: 

  • Full facial assessment 
  • Individualized treatment planning 
  • Estimation of expectations and differentiation between temporary versus permanent solutions 
  • Networking with weight loss and primary care providers 

This entire journey is a process of educating the patient so that they understand that facial aging due to fat loss is normal and can be managed with either non-invasive or minimally invasive treatments. 

Looking Ahead: Regenerative Aesthetics and Innovation

Regenerative aesthetics are emerging with the latest techniques including platelet-rich plasma (PRP), exosomes, and biostimulators that show great promise for long-term skin quality and volume restoration after weight loss (Goldman & Wollina, 2020). Such advances would promote the combination of the indicated techniques with conventional approaches toward comprehensive practices and individualized plans for aesthetic medicine practitioners. 

GLP-1 agents have a widespread use and with this comes the transformation of health outcomes together with new aesthetic preferences. Due to the significant modifications in body composition with time, especially with modifying facial structure, aesthetic medicine is an integral part of this journey for the patient. Loss of volume and skin laxity would be managed by compassionate experts, thus empowering the patients to celebrate their journey to weight reduction with complete confidence and dignity.  

As this trend gathers momentum, aesthetic practitioners must embrace adaptive strategies and engage in a multidisciplinary collaboration, emphasizing the importance of patient education. Where the medical aspect of weight loss truly marries the aesthetic aspect of patient care marks the beginning of a new area in preventive and personalized beauty. 

References

  1. Avram, M. M., Biesman, B. S., & Carruthers, J. (2023). The aesthetic implications of GLP-1 mediated weight loss: A new frontier in facial rejuvenation. Aesthetic Surgery Journal, 43(2), 198–205. https://doi.org/10.1093/asj/sjac264 
  2. de Sousa, A., Kapoor, H., & Jethwani, K. (2022). Body image issues and psychological distress after rapid weight loss: A growing concern in aesthetic practice. Indian Journal of Psychiatry, 64(5), 395–401. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_367_21 
  3. Goldman, A., & Wollina, U. (2020). Modern concepts of facial rejuvenation post-weight loss: Aesthetic strategies for mature patients. Journal of Cutaneous and Aesthetic Surgery, 13(4), 259–266. 
  4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide on weight loss maintenance in adults with obesity: The STEP 4 trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 
  5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989–1002. https://doi.org/10.1056/NEJMoa2032183 

RELATED ARTICLESMORE FROM AUTHOR